You are here

JNJ

Johnson & Johnson assures docs and patients its Janssen pharma unit 'Never Stops'

Johnson & Johnson assures docs and patients its Janssen pharma unit 'Never Stops'

Fierce Pharma

DTC advertising

corporate branding

Flag link:

J&J tries to strike the right note with Ottava

J&J tries to strike the right note with Ottava

EP Vantage

robotic surgery

Intuitive Surgical

Flag link:

Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

Motley Fool

Moderna Therapeutics

Flag link:

J&J, following BMS, pledges $100M to address racism and health inequities

J&J, following BMS, pledges $100M to address racism and health inequities

Fierce Pharma

Flag link:

J&J, erring on caution, tests new 2-dose regimen for COVID-19 vaccine

J&J, erring on caution, tests new 2-dose regimen for COVID-19 vaccine

Fierce Biotech

clinical trials

Flag link:

J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial

J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial

Endpoints

clinical trials

Flag link:

J&J tops list of healthcare supply chains amid COVID vaccine effort—and Pfizer wins kudos, too

J&J tops list of healthcare supply chains amid COVID vaccine effort—and Pfizer wins kudos, too

Fierce Pharma

Flag link:

Johnson & Johnson confident in 1B dose goal for COVID vaccine next year, looking ahead to 2022

Johnson & Johnson confident in 1B dose goal for COVID vaccine next year, looking ahead to 2022

Fierce Pharma

drug manufacturing

Flag link:

Pfizer's COVID-19 vaccine looks impressive, but Sanofi, J&J and Novavax shots eye a logistics edge

Pfizer's COVID-19 vaccine looks impressive, but Sanofi, J&J and Novavax shots eye a logistics edge

Fierce Pharma

Flag link:

J&J plans to test its COVID-19 vaccine in ages 12-18 soon

J&J plans to test its COVID-19 vaccine in ages 12-18 soon

Reuters

clinical trials

Flag link:

[video+transcript]What Are the Differences Between the Leading Coronavirus Vaccine Candidates?

[video+transcript]What Are the Differences Between the Leading Coronavirus Vaccine Candidates?

Motley Fool

Moderna Therapeutics

Flag link:

J&J's Darzalex Proves Effective in Yet Another Multiple Myeloma Indication

J&J's Darzalex Proves Effective in Yet Another Multiple Myeloma Indication

BioSpace

clinical trials

Multiple Myeloma

Flag link:

2 Late-Stage Coronavirus Vaccine Candidates in Limbo

2 Late-Stage Coronavirus Vaccine Candidates in Limbo

Motley Fool

clinical trials

Flag link:

Moderna Works With International Regulators to Speed Up COVID-19 Vaccine Review Process

Moderna Works With International Regulators to Speed Up COVID-19 Vaccine Review Process

BioSpace

Moderna Therapeutics

Flag link:

What The Pause In The Johnson & Johnson And Eli Lilly Covid Drug Trials May Mean

What The Pause In The Johnson & Johnson And Eli Lilly Covid Drug Trials May Mean

Forbes

clinical trials

Flag link:

J&J pause adds to adenovirus vaccine doubts

J&J pause adds to adenovirus vaccine doubts

EP Vantage

clinical trials

Flag link:

Johnson & Johnson's immunology, cancer blockbusters deliver Q3 growth—and fuel hopes for 2021

Johnson & Johnson's immunology, cancer blockbusters deliver Q3 growth—and fuel hopes for 2021

Fierce Pharma

Flag link:

J&J halts studies of coronavirus vaccine due to participant's illness

J&J halts studies of coronavirus vaccine due to participant's illness

BioPharma Dive

clinical trials

Flag link:

J&J wins FDA approval for ablation catheter

J&J wins FDA approval for ablation catheter

Medical Tubing and Extrusion

Biosense Webster

Thermocool SmartTouch SF Catheter

ablation catheter

Flag link:

Gilead rescues biopharma’s takeout scene

Gilead rescues biopharma’s takeout scene

EP Vantage

Gilead Sciences

Momenta Pharmaceuticals

Principia Biopharma

Tizona Therapeutics

Flag link:

Pages